The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
New therapeutic strategies raised to prevent and resist metastasis in lymph nodes of breast cancer
4.
An understudied type of breast cancer poses a lurking threat
5.
More men with prostate cancer are avoiding unnecessary surgery
1.
Evidence-Based Approaches in Hematology for Modern Medicine
2.
The Importance of Having a Quick and Effective Heparin Antidote
3.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
4.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
5.
Targeted Therapies for Breast Cancer: What’s New?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
4.
Importance of Cancer Screening and Early Detection
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation